UN agency claims it saved the government $10 billion
According to the United Nations Office for Project Services (Unops), the work carried out in Mexico to purchase medicines and healing material fulfilled the objective of opening the market and allowed the government economic benefits of 10 billion dollars. pesos. Thus, although it only allocated 28 percent of total public sector spending, it stands out that the number of providers went from 18 in 2018 to 99 in 2022.
The agency reported the above after last October 5, in his appearance in the Chamber of Deputies, the director of the Institute of Health for Well-being (Insabi), Juan Antonio Ferrer, announced that for the acquisitions of 2023-2024, already The services of the United Nations agency will not be required.
Since the signing of the agreement between Unops and Insabi in July 2020, the pharmaceutical industry has warned that the federal government was making an unnecessary expense since it paid Unops around 130 million pesos, with the supposed objective of obtaining economic savings and expanding its purchasing power abroad.
It should be remembered that the collaboration project with Unops arose from the need observed by the Executive Power to end the monopolization of the market by a dozen companies that distribute medicines and healing materials.
Yesterday, Unops assured that with its international transparency standards, it obtained economic benefits of 10 billion pesos for the Mexican government. However, it omitted to specify the period in which such savings were achieved.
He said that he made purchases at fair and efficient prices. He even pointed out that the amount saved is significantly higher than the operating costs of Unops.
The agency also highlighted that it has contributed to the objective of strengthening the capacities of the National Health System through best international practices.
The major issues for the further development of the pharmaceutical market will be discussed at the Mexican Pharmaceutical Forum that will be organized by the Global Pharmaceutical Leaders’ Club on the 29-30th November 2022 in Mexico City. Secure your delegate place ASAP! Registration is here: https://mexicanpharmaforum.com/registration/
Takeda appoints Hernán Porcile as its new General Manager in Mexico
October 24, 2022
Solid growth of the Medical Devices sector in Mexico
October 19, 2022
Sandoz Receives Certification for Transparent Practices
October 19, 2022